European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases

Gelinas R, Leach E, Horvath G, Laksman Z . Molecular Autopsy Implicates Primary Carnitine Deficiency in Sudden Unexplained Death and Reversible Short QT Syndrome. Can J Cardiol. 2019; 35(9):1256.e1-1256.e2. DOI: 10.1016/j.cjca.2019.05.014. View

Mega J, Stitziel N, Smith J, Chasman D, Caulfield M, Devlin J . Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet. 2015; 385(9984):2264-2271. PMC: 4608367. DOI: 10.1016/S0140-6736(14)61730-X. View

Goldenberg I, Horr S, Moss A, Lopes C, Barsheshet A, McNitt S . Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol. 2010; 57(1):51-9. PMC: 3332533. DOI: 10.1016/j.jacc.2010.07.038. View

Li Q, Huang H, Liu G, Lam K, Rutberg J, Green M . Gain-of-function mutation of Nav1.5 in atrial fibrillation enhances cellular excitability and lowers the threshold for action potential firing. Biochem Biophys Res Commun. 2009; 380(1):132-7. DOI: 10.1016/j.bbrc.2009.01.052. View

Roston T, Wei J, Guo W, Li Y, Zhong X, Wang R . Clinical and Functional Characterization of Ryanodine Receptor 2 Variants Implicated in Calcium-Release Deficiency Syndrome. JAMA Cardiol. 2021; 7(1):84-92. PMC: 8567190. DOI: 10.1001/jamacardio.2021.4458. View

Choi S, Weng L, Roselli C, Lin H, Haggerty C, Shoemaker M . Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation. JAMA. 2018; 320(22):2354-2364. PMC: 6436530. DOI: 10.1001/jama.2018.18179. View

Nademanee K, Haissaguerre M, Hocini M, Nogami A, Cheniti G, Duchateau J . Mapping and Ablation of Ventricular Fibrillation Associated With Early Repolarization Syndrome. Circulation. 2019; 140(18):1477-1490. DOI: 10.1161/CIRCULATIONAHA.118.039022. View

Zipes D, Wellens H . Sudden cardiac death. Circulation. 1998; 98(21):2334-51. DOI: 10.1161/01.cir.98.21.2334. View

McKeown P, Merlini P, Berzuini C, Bernardinelli L, Peyvandi F, Tubaro M . Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009; 41(3):334-41. PMC: 2681011. DOI: 10.1038/ng.327. View

10.

Ouellette A, Mathew J, Manickaraj A, Manase G, Zahavich L, Wilson J . Clinical genetic testing in pediatric cardiomyopathy: Is bigger better?. Clin Genet. 2017; 93(1):33-40. DOI: 10.1111/cge.13024. View

11.

Matsa L, Sagurthi S, Ananthapur V, Nalla S, Nallari P . Endothelin 1 gene as a modifier in dilated cardiomyopathy. Gene. 2014; 548(2):256-62. DOI: 10.1016/j.gene.2014.07.043. View

12.

Gillmore J, Booth D, Pepys M, Hawkins P . Hereditary cardiac amyloidosis associated with the transthyretin Ile122 mutation in a white man. Heart. 1999; 82(3):e2. PMC: 1729180. DOI: 10.1136/hrt.82.3.e2. View

13.

Lambert S, Gil L, Jupp S, Ritchie S, Xu Y, Buniello A . The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation. Nat Genet. 2021; 53(4):420-425. PMC: 11165303. DOI: 10.1038/s41588-021-00783-5. View

14.

Fatkin D, MacRae C, Sasaki T, WOLFF M, Porcu M, Frenneaux M . Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med. 1999; 341(23):1715-24. DOI: 10.1056/NEJM199912023412302. View

15.

Sotoodehnia N, Isaacs A, de Bakker P, Dorr M, Newton-Cheh C, Nolte I . Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet. 2010; 42(12):1068-76. PMC: 3338195. DOI: 10.1038/ng.716. View

16.

Visscher P, Wray N, Zhang Q, Sklar P, McCarthy M, Brown M . 10 Years of GWAS Discovery: Biology, Function, and Translation. Am J Hum Genet. 2017; 101(1):5-22. PMC: 5501872. DOI: 10.1016/j.ajhg.2017.06.005. View

17.

Fuster V, Ryden L, Cannom D, Crijns H, Curtis A, Ellenbogen K . 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice.... J Am Coll Cardiol. 2011; 57(11):e101-98. DOI: 10.1016/j.jacc.2010.09.013. View

18.

Giudicessi J, Lieve K, Rohatgi R, Koca F, Tester D, van der Werf C . Assessment and Validation of a Phenotype-Enhanced Variant Classification Framework to Promote or Demote RYR2 Missense Variants of Uncertain Significance. Circ Genom Precis Med. 2019; 12(5):e002510. DOI: 10.1161/CIRCGEN.119.002510. View

19.

Koncz I, Gurabi Z, Patocskai B, Panama B, Szel T, Hu D . Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome. J Mol Cell Cardiol. 2014; 68:20-8. PMC: 3943882. DOI: 10.1016/j.yjmcc.2013.12.012. View

20.

Righi D, Silvetti M, Drago F . Sinus bradycardia, junctional rhythm, and low-rate atrial fibrillation in Short QT syndrome during 20 years of follow-up: three faces of the same genetic problem. Cardiol Young. 2015; 26(3):589-92. DOI: 10.1017/S1047951115001432. View